Can You Go on Mounjaro for a Month — and Should You?

The decision you're actually making when you ask about a month

Most people asking this question are weighing one of a few things: cost, uncertainty about whether the medicine will suit them, a short-term event like a wedding or holiday, or simply wanting to test the water before committing. Each of those is a reasonable starting point for a conversation with a prescriber. None of them changes the underlying biology.

The first four weeks of Mounjaro are spent entirely at the 2.5 mg starter dose. That dose exists for one reason: to let your digestive system settle. Nausea, indigestion and loose stools are common in the early weeks, and the low starting dose reduces how sharp those effects feel. By the time a four-week course ends, most people are only just finishing their first pen. The active weight-management phase of treatment typically begins once titration gets underway, something you can read more about on our tirzepatide overview page.

So the decision is not really "one month versus longer". It's whether the reasons driving the one-month idea can be addressed in a way that still makes clinical sense. A prescriber at nume will ask about those reasons and work through them with you honestly. Our clinical team approaches these conversations without any pressure toward a particular course length.

What the evidence says about how long treatment takes to work

In the SURMOUNT-1 trial, which followed over 2,500 adults with obesity over 72 weeks, average body-weight reduction at the highest dose reached around 20–21%. That figure is the result of sustained, stepped treatment across well over a year, as documented in the NEJM publication of SURMOUNT-1. The data from earlier time points in the trial show more modest numbers, meaningful, but not the headline figure.

After one month at 2.5 mg, most participants had experienced appetite reduction and some early weight change, but the trajectory was still establishing itself. Weight loss with tirzepatide tends to be progressive: the body responds to each dose increase, and the cumulative effect builds over several months. Stopping at four weeks means leaving most of that trajectory unexplored.

That said, some people do find one month useful as a structured starting point, particularly if they are genuinely uncertain whether they can tolerate the medicine at all. NICE's appraisal of tirzepatide (TA1026) recommends reviewing progress at six months on the highest tolerated dose; by comparison, four weeks gives a prescriber very little to assess.

What happens when you stop after a month

Tirzepatide does not produce permanent changes to appetite regulation. When you stop, the GIP and GLP-1 receptor activity that was suppressing your hunger gradually subsides. For most people, appetite returns to baseline over the following weeks, and without sustained dietary and activity habits to fall back on, weight regain is common. This is not a failure unique to Mounjaro, it reflects the biology of how these medicines work.

This is worth knowing before you start, not after. A short course without a plan for what follows is unlikely to deliver lasting benefit. If cost is the reason you're considering a short course, it's worth understanding what a full treatment price actually includes, our weight loss treatment overview sets out the picture clearly. Thinking about a three-month course instead may allow enough time to reach a meaningful dose and make a more informed decision about continuing.

If your concern is more about whether the medicine suits you physically, a prescriber can talk through your medical history in detail before you commit to anything. At nume (sorry, at nume

At nume) at nume, a real clinician reads your consultation the same day. Your answers go to a GPhC-registered Independent Prescriber, not into an automated queue. If you are approved, your first pen is dispatched the same day (for orders placed before 12pm, Monday to Friday) and arrives with DPD the next working day, in plain, unbranded packaging. There are no subscriptions and no auto-renewals; if you want to stop after a month, you simply don't reorder.

Who might a short course be appropriate for, and who should think carefully

There is no clinical rule against a one-month course. For some people, a single pen is a reasonable first step: you can read through our dedicated page on using Mounjaro for a month to understand what that first step realistically involves, you talk to a prescriber about whether to continue, and you make a properly informed decision from there rather than from speculation. That is a legitimate approach.

It is less suitable as a quick fix before a specific event. Mounjaro is not licensed, and should not be framed, as a short-term cosmetic intervention, the MHRA's public guidance on GLP-1 medicines is clear that these treatments are not assessed for quick or cosmetic weight loss. A prescriber will assess whether treatment is clinically appropriate for you as an individual, taking your health history and goals into account.

People who are pregnant, breastfeeding, or actively trying to conceive should not take Mounjaro. The medicine is not licensed for under-18s. If you have a history of pancreatitis or certain other conditions, your prescriber will need to consider those carefully before proceeding. A longer-term view of your health (rather than a single month) tends to produce the most useful clinical conversation. If you're still weighing up whether taking Mounjaro for one month makes sense for you, speaking with a prescriber is the most direct way to get an answer that is specific to you, and our one-month-only course page covers the question from a slightly different angle too.